BioLineRx Dividends and Buybacks
Dividend criteria checks 0/6
BioLineRx does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-68.9%
Buyback Yield
| Total Shareholder Yield | -68.9% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Does BioLineRx (TLV:BLRX) Have A Healthy Balance Sheet?
Apr 02
BioLineRx (TLV:BLRX) Has Debt But No Earnings; Should You Worry?
Aug 25Health Check: How Prudently Does BioLineRx (TLV:BLRX) Use Debt?
Apr 05Is BioLineRx (TLV:BLRX) A Risky Investment?
Jun 17Is BioLineRx (TLV:BLRX) Using Debt In A Risky Way?
Feb 26Is BioLineRx (TLV:BLRX) Using Debt In A Risky Way?
Oct 17Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if BLRX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if BLRX's dividend payments have been increasing.
Dividend Yield vs Market
| BioLineRx Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (BLRX) | n/a |
| Market Bottom 25% (IL) | 2.2% |
| Market Top 25% (IL) | 6.2% |
| Industry Average (Biotechs) | 1.1% |
| Analyst forecast (BLRX) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate BLRX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate BLRX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate BLRX's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as BLRX has not reported any payouts.